Table 1.
Baseline patient demographics and characteristics. AC, cancer patients after gastrectomy and treatment without probiotic combination; ACP, cancer patients after gastrectomy and treatment with probiotic combination.
| Variable | AC Group (N=50) | ACP Group (N=50) | P value |
|---|---|---|---|
| Percentage of total enrollment, No. (%) | 50 (50.00) | 50 (50.00) | / |
| Male: female, n:n (%:%) | 41:9 (82.00:18:00) | 43:7 (86.00:14.00) | 0.585 |
| Age, y | 64.00 (56.75-69.25) | 60.00 (51.75-67.25) | 0.122 |
| Tumor category, No. (%) | |||
| T0 | 0 (0.00) | 1 (2.00) | 0.510 |
| T1 | 6 (12.00) | 3 (6.00) | |
| T2 | 5 (10.00) | 3 (6.00) | |
| T3 | 9 (18.00) | 7 (14.00) | |
| T4 | 30 (60.00) | 36 (72.00) | |
| Node category, No. (%) | |||
| N0 | 16 (32.00) | 16 (32.00) | 0.772 |
| N1 | 23 (46.00) | 22 (44.00) | |
| N2 | 6 (12.00) | 9 (18.00) | |
| N3 | 5 (10.00) | 3 (6.00) | |
| M category, No. (%) | |||
| M0 | 50 (100.00) | 50 (100.00) | / |
| TNM category, No. (%) | |||
| TNM1 | 9 (18.00) | 6 (12.00) | 0.347 |
| TNM2 | 13 (26.00) | 9(18.00) | |
| TNM3 | 28 (54.00) | 35 (70.00) |